The pipeline and market for psoriasis drugs

Nature.com - 31 Jan 2024
Deucravacitinib (Table 1) is an oral selective inhibitor of tyrosine kinase 2 (TYK2), which mediates signalling of cytokines involved in the pathogenesis of ...

Therapeutic application of circular RNA aptamers in a mouse model of psoriasis

Nature.com - 23 Apr 2024
Therapeutic application of circular RNA aptamers in a mouse model of psoriasis ...

Is Psoriasis Contagious? Stigma, Facts, Reassurance

Verywell Health - 20 Apr 2024
Is Psoriasis Contagious? Stigma, Facts, Reassurance ...

6 ways to manage psoriasis in summer

Health shots - 23 Apr 2024
6 ways to manage psoriasis in summer ...

Risankizumab Shows Efficacy in Patients With Active Psoriatic Arthritis Through 52 Weeks

AJMC.com Managed Markets Network - 22 Apr 2024
Risankizumab Shows Efficacy in Patients With Active Psoriatic Arthritis Through 52 Weeks ...

The wide-ranging effects of psoriasis

Harvard Health - 01 Apr 2024
The wide-ranging effects of psoriasis ...

Managing Psoriasis in BIPOC Skin

Everyday Health - 17 Apr 2024
Managing Psoriasis in BIPOC Skin ...

Diagnosing Psoriatic Arthritis for the Dermatologist: Guidance From the Experts

Medscape - 17 Apr 2024
Diagnosing Psoriatic Arthritis for the Dermatologist: Guidance From the Experts ...

Impact of the Expanding Treatment Landscape on the Treatment Algorithm of Plaque Psoriasis

MD Magazine - 19 Apr 2024
Impact of the Expanding Treatment Landscape on the Treatment Algorithm of Plaque Psoriasis ...

From Earth to Skin: Reviewing the Role of Environmental Factors in Dermatologic Conditions

Dermatology Times - 22 Apr 2024
From Earth to Skin: Reviewing the Role of Environmental Factors in Dermatologic Conditions ...

Deciphering p19 Targeting by Anti-IL-23 Biologics: Insights into Psoriasis Treatment Efficacy

Physician's Weekly - 22 Apr 2024
Deciphering p19 Targeting by Anti-IL-23 Biologics: Insights into Psoriasis Treatment Efficacy ...

FDA Approves Selarsdi as Biosimilar to Stelara for Psoriasis and Psoriatic Arthritis

Specialty Pharmacy Continuum - 19 Apr 2024
FDA Approves Selarsdi as Biosimilar to Stelara for Psoriasis and Psoriatic Arthritis ...

FDA Approves Ustekinumab Biosimilar to Stelara for Treatment of Plaque Psoriasis

Pharmacy Times - 17 Apr 2024
FDA Approves Ustekinumab Biosimilar to Stelara for Treatment of Plaque Psoriasis ...

Plaque psoriasis plagues Marietta man for over 30 years until new treatment

FOX 5 Atlanta - 16 Apr 2024
Plaque psoriasis plagues Marietta man for over 30 years until new treatment ...

Generalized pustular psoriasis (GPP): a rare, chronic, systemic disease

Boehringer Ingelheim - 23 Mar 2024
Generalized pustular psoriasis (GPP): a rare, chronic, systemic disease ...

11 Drugs That Can Trigger Psoriasis Flares

Verywell Health - 10 Apr 2024
11 Drugs That Can Trigger Psoriasis Flares ...

FDA Approves Second Ustekinumab Biosimilar

Medscape - 17 Apr 2024
FDA Approves Second Ustekinumab Biosimilar ...

European Union Approves Bimekizumab to Treat HS

Dermatology Times - 22 Apr 2024
European Union Approves Bimekizumab to Treat HS ...

Single-cell analysis of psoriasis resolution demonstrates an inflammatory fibroblast state targeted by IL-23 blockade

Nature.com - 30 Jan 2024
Single-cell analysis of psoriasis resolution demonstrates an inflammatory fibroblast state targeted by IL-23 blockade ...

Bridging the gap in Generalized Pustular Psoriasis (GPP)

Boehringer Ingelheim - 22 Mar 2024
Bridging the gap in Generalized Pustular Psoriasis (GPP) ...

Psoriasis